LSH-TA project

Project LSH-TA Overview
media content
Project Goals
Innovative treatments
Patients' access to innovative treatments
Training
Opportunities for training and employment of young researchers.
Spokes' growth
Support the growth and qualification of second-level spokes, with a particular focus on institutions in southern Italy.
Technological platforms
Creation of high-tech impact platforms that can support research institutions in Italy in the clinical translation of new Advanced Therapy products.
National collaborative consortium.
Establish a well-integrated national collaborative consortium, dedicated to establishing a complete pathway from preclinical development to the clinical use of Advanced Therapy medicinal products, including the production of products in compliance with Good Manufacturing Practices (GMP)
What the project is about
media content

01

Development of gene therapy platforms for the treatment of hereditary diseases

02

Development of therapy with genetically modified cells for the treatment of cancer

03

Development of diseases based on induced pluripotent stem cells for tissue regeneration.

04

Development and production of cellular therapies with immunomodulatory properties or aimed at restoring specific immunity against pathogens and tumors

05

Development and production of biomaterials or tissues for tissue engineering

06

Management of governance and communication/dissemination of results
Project key points
Complete development pathway from preclinical to clinical
National collaborative consortium for the development of ATMPs
Strengthening of the scientific resources already present in the Italian territory
Facilitate and guarantee access to innovative therapies for all patients
Opportunity to attract national and international investments
Support Italian researchers in the clinical translation of their innovative research
Support for the growth of peripheral centers by allowing access to ARMPs throughout the Italian territory.
Logo